Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
311.81
+2.69 (0.87%)
At close: Oct 6, 2025, 4:00 PM EDT
311.69
-0.12 (-0.04%)
After-hours: Oct 6, 2025, 4:00 PM EDT

Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface.

It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.

The company sells its products to end-users through the pharmacy channel; and independent distributors.

Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation
Insulet logo
CountryUnited States
Founded2000
IPO DateMay 15, 2007
IndustryMedical Devices
SectorHealthcare
Employees3,900
CEOAshley McEvoy

Contact Details

Address:
100 Nagog Park
Acton, Massachusetts 01720
United States
Phone978 600 7000
Websiteinsulet.com

Stock Details

Ticker SymbolPODD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001145197
CUSIP Number45784P101
ISIN NumberUS45784P1012
Employer ID04-3523891
SIC Code3841

Key Executives

NamePosition
Ashley A. McEvoyChief Executive Officer, President and Director
Ana Maria ChadwickExecutive Vice President and Chief Financial Officer
Eric BenjaminExecutive Vice President and Chief Operating Officer
John Wodick Kapples J.D.Senior Vice President and General Counsel
Amit GulianiChief Technology Officer
Clare TrachtmanVice President of Investor Relations
Laetitia CousinSenior Vice President of Regulatory Affairs, Quality Assurance and Compliance
Angela Geryak WiczekSenior Director of Corporate Communications
Philip HildaleSenior Vice President of Sales and Customer Care
Andrew IsaacsonSenior Vice President of Strategy and Corporate Development

Latest SEC Filings

DateTypeTitle
Sep 16, 2025144Filing
Sep 16, 20258-KCurrent Report
Sep 8, 2025144Filing
Sep 8, 2025144Filing
Aug 21, 2025144Filing
Aug 13, 2025SCHEDULE 13G/AFiling
Aug 7, 202510-QQuarterly Report
Aug 7, 2025144Filing
Aug 7, 20258-KCurrent Report
Jun 13, 2025144Filing